PosiFunda · Fundamentals

Takeda Pharmaceutical Company Limited

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (5)

Takeda Pharmaceutical Company Limited made a loss over the last year.

Compared with Healthcare companies in Japan.

P/E ratio

Loss

Takeda Pharmaceutical Company Limited made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

1.34

The share price is 1.34 times Takeda Pharmaceutical Company Limited's book value per share, lower than 60% of Healthcare companies in Japan.

Market cap

¥10,157.1 B

The total market value of all of Takeda Pharmaceutical Company Limited's shares at today's price (share price × number of shares), larger than 98% of Healthcare companies in Japan. PosiCap size class: Tito Cap.

Return on equity (ROE)

-2.3%

Takeda Pharmaceutical Company Limited lost 2.3% of its shareholders' money over the last year, lower than 95% of Healthcare companies in Japan.

Dividend yield

3.19%

Takeda Pharmaceutical Company Limited pays 3.19% of its share price as dividends a year, higher than 66% of dividend-paying Healthcare companies in Japan.

Questions

What is Takeda Pharmaceutical Company Limited's return on equity?

Takeda Pharmaceutical Company Limited lost 2.3% of its shareholders' money over the last year, lower than 95% of Healthcare companies in Japan.

Does Takeda Pharmaceutical Company Limited pay a dividend?

Yes. Takeda Pharmaceutical Company Limited pays 3.19% of its share price as dividends a year, higher than 66% of dividend-paying Healthcare companies in Japan.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.